Just bought today. Key for me -
Full year guidance has been affirmed; – H1 FY19 underlying EBITDA for the Group was $9.6m and full year guidance is a range of $27.5m - $30.5m
– a recovery in the Enterprise division in H2 underpins the achievement of guidance
• We are on-track at the end of H1 FY19 and momentum is building with each month
Looking at the Bell Potter research, previous underlying Evita guidance was 22 - 25m. New guidance is 27.5 - 30.5m Evita. Much better. I think it is way undervalued and will be a positive re-rate from brokers tomorrow.
Ann: 2019 Half Year Results Investor Presentation, page-6
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 5GN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.005(3.33%) |
Mkt cap ! $48.52M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.5¢ | 15.0¢ | $21.95K | 145.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 6187190 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 1707190 | 22 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| 5GN (ASX) Chart |